跳至主要内容
临床试验/EUCTR2004-001253-29-ES
EUCTR2004-001253-29-ES进行中(未招募)1 期

Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, after first line chemotherapy

PharmaMar SA0 个研究点目标入组 34 人开始时间: 2004年9月16日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Histologically proven diagnosis of Non Small Cell Lung Cancer Stage IIIB with pleural effusion and Stage IV ,with progressive disease within the last four months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Previous Chemotherapy within the last four weeks

研究者

发起方
PharmaMar SA

相似试验